BDBM349743 2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridin-2-yl}-2-methylpiperazin-1-yl]methyl}-1-(1,3-oxazol-4-ylmethyl)-1H-benzimidazole-6-carboxylic acid::US10208019, Example 10A-13
SMILES: C[C@H]1CN(CCN1Cc1nc2ccc(cc2n1Cc1cocn1)C(O)=O)c1cccc(OCc2ccc(Cl)cc2F)n1
InChI Key: InChIKey=XVNUBAZDBSFGQA-IBGZPJMESA-N
Data: 2 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349743 (2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 170 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Glucagon-like peptide 1 receptor (Homo sapiens (Human)) | BDBM349743 (2-{[(2S)-4-{6-[(4-chloro-2-fluorobenzyl)oxy]pyridi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.10 | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description GLP-1R-mediated agonist activity was determined with a cell-based functional assay utilizing an HTRF (Homogeneous Time-Resolved Fluorescence) cAMP de... | US Patent US10208019 (2019) BindingDB Entry DOI: 10.7270/Q2WH2S4X | |||||||||||
More data for this Ligand-Target Pair |